Business
ASX rises 0.9pc, buoyed by Victoria easing, vaccine development – The Australian Financial Review
The Australian sharemarket closed at a seven-month high on Monday as Victoria eased lockdown restrictions and on news of progress towards a COVID-19 vaccine.
“The crisis support has been significant and the tapering of such will present a drag. That said, the fiscal pivot is meaningful in size and focus. This combined with liquid and willing, monetary support allows for some calibration of an earnings recovery and more normalcy in the cycle.”
CSL led the market gains and a broadly firmer health sector with the British National Health Service deputy chief medical officer Jonathan Van-Tam suggesting the Oxford University vaccine being manufactured by …
-
Noosa News18 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
Business23 hours agoBell Potter names more of the best ASX 200 stocks to buy in April
-
General13 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate
-
Noosa News22 hours agoTeenager sentenced to 12 years for ‘heinous’ Acacia Ridge murder